Tear Sheet
Company Overview
HTG Molecular Diagnostics, Inc.'s mission is to empower precision medicine at the local level. The company’s proprietary HTG EdgeSeq technology automates multiplexed molecular profiling of nucleic acids in a wide variety of solid and liquid samples, even when very limited in amount. The extraction free workflow paired with detection by next-generation sequencing offers many advantages and enables meaningful applications, such as identifying biomarkers important for precision medicine, understanding the clinical relevance of these biomarkers, and, ultimately, identifying treatment options.
Events
Date | Event Details |
---|---|
Summary Toggle Nov 10, 2020 at 4:30 PM EST | |
Summary Toggle Aug 11, 2020 at 4:30 PM EDT | |
Summary Toggle Feb 26, 2020 at 10:00 AM EST | |
Summary Toggle Dec 13, 2019 from 12:00 PM to 1:30 PM EST | |
Summary Toggle Nov 12, 2019 at 4:30 PM EST |
Stock Quote
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Stock Chart
SEC Filings
Filing date | Description |
---|---|
Report of unscheduled material events or corporate event |
|
Securities offered to employees pursuant to employee benefit plans |
|
Report of unscheduled material events or corporate event |
|
Report of unscheduled material events or corporate event |
|
Statement of changes in beneficial ownership of securities |